DRUG-DRUG INTERACTION,SHR3680

Clinical trials for DRUG-DRUG INTERACTION,SHR3680 explained in plain language.

Never miss a new study

Get alerted when new DRUG-DRUG INTERACTION,SHR3680 trials appear

Sign up with your email to follow new studies for DRUG-DRUG INTERACTION,SHR3680, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Prostate cancer drug interaction study completed – no direct benefit for patients

Knowledge-focused Completed

This study tested how a new prostate cancer drug (SHR3680) affects the way the body processes three other common drugs: digoxin, rosuvastatin, and metformin. Thirty-six men with prostate cancer took part. The goal was to understand potential drug interactions, not to treat the ca…

Matched conditions: DRUG-DRUG INTERACTION,SHR3680

Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused

Last updated Jun 16, 2026 12:49 UTC

DRUG-DRUG INTERACTION,SHR3680

Get alerted when new DRUG-DRUG INTERACTION,SHR3680 trials appear

Prostate cancer drug interaction study completed – no direct benefit for patients